Company / Operating Cash Flow per Share
Vertex Pharmaceuticals Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$14.13
FY2025
5-year range
-$1.91 / $16.23
FY2021-FY2025
Trend
+839.4%
vs FY2024
Sector context
#8 of 212
Health Care
What the data says
Operating Cash Flow per Share changed +839% YoY in FY2025, a notable deviation from the 9-year average annual change of +131%.
Based on SEC 10-K filings.
14.13 in FY2025 with a 5-year CAGR of +2.4%. Top quartile in the Health Care sector.
Improved from $13.76 to $14.13 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -4.5%
- 5-Year CAGR
- +2.4%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 212This company $14.13 Sector average -$14.72
▼
+196.0% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 839.4% year-over-year.
- Ranks #8 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Strong profit margin: 31.4%
- Strong return on equity: 21.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.13 | +839.4% |
| FY2024 | -$1.91 | -113.9% |
| FY2023 | $13.76 | -15.2% |
| FY2022 | $16.23 | +59.6% |
| FY2021 | $10.17 | -19.0% |
| FY2020 | $12.56 | +104.3% |
| FY2019 | $6.15 | +22.6% |
| FY2018 | $5.02 | +47.4% |
| FY2017 | $3.40 | +255.0% |
| FY2016 | $0.96 | +163.4% |
As of FY2025 · SEC 10-K · Updated Mar 17, 2026